Trial Site Detail

 

Drug:
Ponatinib (Iclusig)
Trial:
POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST (POETIG)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Unknown

 

Universitatsklinikum Essen, West Germany Cancer Center

Hufelandstr. 55     
Essen , 45122
Germany

 

Principal Investigator:
 Sebastian Bauer, MD
Contact:
 Johanna Falkenhorst +49 201 723 84150 johanna.falkenhorst@uk-essen.de
Activation Status of this Site:
 Active
Notes about this Site:
Universitatsklinikum Essen, West Germany Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.